ISOCITRATE DEHYDROGENASE GENE MUTATION
Clinical trials for ISOCITRATE DEHYDROGENASE GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ISOCITRATE DEHYDROGENASE GENE MUTATION trials appear
Sign up with your email to follow new studies for ISOCITRATE DEHYDROGENASE GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental IDH drug trial halted early
Disease control TerminatedThis early-stage trial tested an experimental drug called HMPL-306 in 46 adults with advanced blood cancers that have a specific genetic change (IDH mutation). The goal was to find a safe dose and see if the drug could shrink or control the cancer. The study was terminated early,…
Matched conditions: ISOCITRATE DEHYDROGENASE GENE MUTATION
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
Experimental IDH drug trial halted early
Disease control TerminatedThis early-stage study tested an experimental drug called HMPL-306 in people with advanced solid tumors that have a specific genetic change (IDH mutation). The main goals were to check the drug's safety and find the best dose. The study was terminated early, so results are limite…
Matched conditions: ISOCITRATE DEHYDROGENASE GENE MUTATION
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 20, 2026 11:54 UTC